Deelnemers

Heb je een vraag? Neem gerust contact met ons op.

 

Telefoon: 050 - 36 11 113 (werkdagen van 8.00 - 17.00 uur)

Contactformulier

Researchers

Do you have a question regarding working with Lifelines? Please contact us, we're happy to help you.

Contact us

Pers

We voorzien media graag van informatie en we behandelen graag verzoeken voor interviews, opnames en beeldmateriaal.

Stuur een e-mail

Contact

Dutch Parkinson and Microbiome Study (DUPARM)

The DUPARM study is the first study to investigate the gut microbiota of still untreated Parkinson’s Disease (PD) subjects. Though PD is a brain disease most known for its motor symptoms (eg. tremor), it is believed that the disease might actually start in the gut and spread towards the brain. Different studies have already shown that the gut microbiome of PD patients differs from that of non-affected individuals. These studies were, however, based on already treated subjects, so it is unclear to what extend these differences can be attributed to PD or its medication.

Year of approval

2018

Institute

University Medical Center Groningen

Primary applicant

van Laar, T